3.010EUR+2.73%Mkt Cap: 65.76M EURP/E: —Last update: 2026-06-01
BRAIN Biotech AG provides bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. The company operates through two segments: BRAINBiocatalysts and BRAINBioIncubato…
Industry Peers
Specialty Chemicals102.39BEURP/E 29.2
72.86BUSDP/E 28.4
70.67BUSDP/E 33.9
62.19BUSDP/E 29.4
40.39BTRY—
26.28BCHFP/E 24.7
24.83BUSDP/E 16.0
24.56BSEKP/E 13.3
Indicators:|
Key Statistics
Company
Market Cap65.76M EUR
Enterprise Value59.74M EUR
Revenue (TTM)49.01M EUR
Gross Profit28.64M EUR
Net Income (TTM)-11.74M EUR
Revenue/Share2.243 EUR
Last Price3.010 EUR
Fiscal Year EndSep 2025
MR QuarterDec 2025
Employees276
CountryDE
SectorBasic Materials
IndustrySpecialty Chemicals
ISINDE0005203947
Valuation
P/E (Trailing)—
P/E (Forward)-7.94
PEG—
EV/EBITDA-16.73
EV/Revenue1.22
P/S1.31
P/B34.88
EPS (TTM)-0.51
EPS (Forward)-0.37
52W Range
1.80562% of range3.740
52W High3.740 EUR
52W Low1.805 EUR
Profitability
Gross Margin57.26%
Oper. Margin-16.66%
EBITDA Margin-7.29%
Profit Margin-23.48%
ROE-637.81%
ROA-17.70%
Growth
Revenue Growth-9.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.23M EUR
CapEx (TTM)1.61M EUR
FCF Margin-10.97%
FCF Yield-8.18%
Net Debt-5.15M EUR
Net Debt/EBITDA1.44
Balance Sheet
Debt/Equity4.64
Current Ratio1.48
Quick Ratio0.29
Book Value/Sh0.0840 EUR
Cash/Share0.2360 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)5.500 EUR
Target Range5.000 EUR – 6.500 EUR
# Analysts3
Ownership
Shares Out.21.85M
Float9.09M
Insiders58.36%
Institutions8.22%
Technical
SMA 502.722 (+10.6%)
SMA 2002.521 (+19.4%)
Beta0.67
S&P 52W Chg27.70%
Avg Vol (30d)9.49K
Avg Vol (10d)10.10K
Technical Indicators
RSI (14)49.8
MACD0.0675
MACD Signal0.1183
MACD Hist.-0.0508
BB Upper3.432 EUR
BB Middle3.084 EUR
BB Lower2.736 EUR
BB Width22.59%
ATR (14)0.1997 EUR
Vol Ratio (20d)0.27x